OTSUKA
Updates & Highlights
Otsuka Fails to Reverse Generic’s Win Over Kidney Drug Patents
Otsuka Fails to Reverse Generic’s Win Over Kidney Drug Patents
Bloomberg Law News · about 5 hours ago
We Like The Quality Of Otsuka's (TSE:4768) Earnings
We Like The Quality Of Otsuka's (TSE:4768) Earnings
simplywall.st · 13 days ago
Assessing Otsuka (TSE:4768) Valuation After First Quarter Earnings And Recent Share Price Reaction
Assessing Otsuka (TSE:4768) Valuation After First Quarter Earnings And Recent Share Price Reaction
simplywall.st · 14 days ago
Recent Openings
View all 2 jobsAll Jobs
Culture & Mission
Benefits & Perks
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Learning Budget
Professional development
Generous PTO
Paid time off
Competitive Salary
Market-rate compensation
Remote Work
Work from anywhere flexibility
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Otsuka?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company →News & Press
20 recentOtsuka Fails to Reverse Generic’s Win Over Kidney Drug Patents
Otsuka Fails to Reverse Generic’s Win Over Kidney Drug Patents
Bloomberg Law News · about 5 hours ago
We Like The Quality Of Otsuka's (TSE:4768) Earnings
We Like The Quality Of Otsuka's (TSE:4768) Earnings
simplywall.st · 13 days ago
Assessing Otsuka (TSE:4768) Valuation After First Quarter Earnings And Recent Share Price Reaction
Assessing Otsuka (TSE:4768) Valuation After First Quarter Earnings And Recent Share Price Reaction
simplywall.st · 14 days ago
MHRA approves Otsuka’s Dawnzera
MHRA approves Otsuka’s Dawnzera
The Pharma Letter · 14 days ago
Ai Otsuka to produce high school duo Pasmal
Ai Otsuka to produce high school duo Pasmal
tokyohive · 15 days ago
Otsuka Boosts Capital in U.S. Clinical Nutrition Unit to Expand Operations
Otsuka Boosts Capital in U.S. Clinical Nutrition Unit to Expand Operations
TipRanks · 15 days ago
UBS upgrades Otsuka Holdings stock rating on pipeline strength
UBS upgrades Otsuka Holdings stock rating on pipeline strength
Investing.com · 24 days ago
Otsuka Holdings Co., Ltd. 2026 Q1 - Results - Earnings Call Presentation (OTCMKTS:OTSKY) 2026-04-28
Otsuka Holdings Co., Ltd. 2026 Q1 - Results - Earnings Call Presentation (OTCMKTS:OTSKY) 2026-04-28
Seeking Alpha · 24 days ago
Hands-On: The Otsuka Lotec No.8 Refines Jiro Katayama's Industrial Language
Hands-On: The Otsuka Lotec No.8 Refines Jiro Katayama's Industrial Language
Monochrome Watches · 28 days ago
Breaking: FDA Awards Priority Review Vouchers to Otsuka, Compass, and Usona
Breaking: FDA Awards Priority Review Vouchers to Otsuka, Compass, and Usona
Psychedelic Alpha · 28 days ago
Otsuka, MSN Labs End Patent Suit Over Lonsurf Cancer Drug Copy
Otsuka, MSN Labs End Patent Suit Over Lonsurf Cancer Drug Copy
Bloomberg Law News · about 1 month ago
Otsuka Pharmaceutical Receives Judges' Special Award at MAFF's 10th Shokuiku Activity Awards "MoguMogu Town" App Recognized for Promoting Food and Nutrition Education｜April 17, 2026｜News Releases | Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Receives Judges' Special Award at MAFF's 10th Shokuiku Activity Awards "MoguMogu Town" App Recognized for Promoting Food and Nutrition Education｜April 17, 2026｜News Releases | Otsuka Pharmaceutic...
otsuka.co.jp · about 1 month ago
Rebecca Ruth Rundall Otsuka Obituary April 9, 2026
Rebecca Ruth Rundall Otsuka Obituary April 9, 2026
Lindquist Mortuary · about 1 month ago
Otsuka to acquire PTSD drugmaker Transcend in $1.2B deal
Otsuka to acquire PTSD drugmaker Transcend in $1.2B deal
BioWorld News · about 2 months ago
Otsuka agrees to acquire Transcend Therapeutics for $1.22bn
Otsuka agrees to acquire Transcend Therapeutics for $1.22bn
Pharmaceutical Technology · about 2 months ago
BREAKING: Otsuka to Acquire Methylone Drug Developer Transcend in $1.23B Deal
BREAKING: Otsuka to Acquire Methylone Drug Developer Transcend in $1.23B Deal
Psychedelic Alpha · about 2 months ago
Biopharma bites: Otsuka's $1.2B outlay for neuro firm, plus Broad's CRISPR battle win
Biopharma bites: Otsuka's $1.2B outlay for neuro firm, plus Broad's CRISPR battle win
FirstWord Pharma · about 2 months ago
Otsuka Pharmaceutical to Acquire Transcend Therapeutics
Otsuka Pharmaceutical to Acquire Transcend Therapeutics
PR Newswire · about 2 months ago
Pharma M&A Roundup: Novartis to Acquire Excellrgy Inc., Otsuka Pharmaceutical to Acquire Transcend Therapeutics
Pharma M&A Roundup: Novartis to Acquire Excellrgy Inc., Otsuka Pharmaceutical to Acquire Transcend Therapeutics
Pharmaceutical Executive · about 2 months ago
Otsuka picks up PTSD drug with $700M Transcend buy
Otsuka picks up PTSD drug with $700M Transcend buy
BioPharma Dive · about 2 months ago